Monitor Drug Safety and pedigree legislation. Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus. Issues
relating to comparative effectiveness and CMS coverage of FDA approved therapies. Issues related to the PPS rule involving stroke
guidelines. Implementation of the follow-on biologics provisions in P.L. 111-148- "Patient Protection and Affordable Care Act". Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus. Issues
relating to comparative effectiveness and CMS coverage of FDA approved therapies. Issues related to the PPS rule involving stroke
guidelines. Proposals to reduce Medicare payment for Part B biologics.
PHA - Pharmacy HCR - Health Issues MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RYAN MACKINNON VASAPOLI AND BERZOK, LLP
1634 I Street, NW Suite 1200, Washington, DC, 20006, US
THOMAS RYAN JEFF MACKINNON JOSEPH V VASAPOLI MATTHEW BERZOK JEFFERY C MORTIER NICK KOLOVOS THOMAS RYAN JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS JEFFERY C MORTIER JEFF MACKINNON THOMAS RYAN JOSEPH V VASAPOLI MATTHEW BERZOK NICK KOLOVOS JEFFERY C MORTIER JEFF MACKINNON